HYDROXYSTILBAMIDINE ISETHIONATE
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Hydroxystilbamidine isethionate is a small-molecule injectable drug approved in 1953 for treating parasitic infections, likely leishmaniasis or related protozoal diseases based on its chemical class. The drug's exact mechanism of action and current indications are not well-documented in available data, suggesting it may be a legacy product with limited modern clinical use.
LOE Approaching
This legacy product faces imminent loss of exclusivity with minimal commercial infrastructure, suggesting very small team size and limited growth opportunities.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This legacy product offers minimal career growth potential, with zero linked job opportunities and approaching loss of exclusivity. Roles would likely focus on managing portfolio wind-down, compliance, and supply continuity rather than innovation or expansion.
Product Manager (Legacy Portfolio)Regulatory Affairs Specialist
Worked on HYDROXYSTILBAMIDINE ISETHIONATE at Sanofi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.